Table 3. Results of patients with AWE after HIFU treatment.
| Variables | Mean ± SD | N (%) |
|---|---|---|
| Lesion volume, cm3 | 7.64±8.95 | |
| Non-perfused volume, cm3 | 18.34±24.08 | |
| Rate of non-perfused volume, % | 1.77±1.08 | |
| Average power, J | 133.50±23.34 | |
| Total treatment time, min | 64±36.77 | |
| Total sonication time, s | 371±29.70 | |
| Total sonication volume, cm3 | 5.70 ±1.27 | |
| Sonication time for 1 cm3, s/cm3 | 75.76±32.18 | |
| Sonication intensity, s/h | 426.14±272.67 | |
| Total energy, J | 49,900±12,586.5 | |
| EEF, J/cm3 | 9,231.06±4,269.43 | |
| CEUS evaluation of lesion incomplete | 7 (8.54) | |
| Intraprocedural VAS* | 5.50±0.71 | |
| Postprocedural VAS | 1±1.41 |
*, P<0.01, Student’s t-tests. AWE, abdominal wall endometriosis; HIFU, high-intensity focused ultrasound; SD, standard deviation; EEF, energy efficiency factor; CEUS, contrast-enhanced ultrasound; VAS, visual analogue scale.